piroximone has been researched along with Coronary Heart Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bussmann, WD; Grohe, G; Klittich, P; Kneissl, GD; Scholz, M; Winkelmann, BW | 1 |
| Thormann, J | 1 |
1 trial(s) available for piroximone and Coronary Heart Disease
| Article | Year |
|---|---|
[Acute hemodynamic effects of piroximone i.v. in patients with severe heart failure].
Topics: Adult; Aged; Cardiac Catheterization; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Dose-Response Relationship, Drug; Electrocardiography, Ambulatory; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Single-Blind Method; Thermodilution | 1995 |
1 other study(ies) available for piroximone and Coronary Heart Disease
| Article | Year |
|---|---|
The influence of clinical intervention on pressure-volume relationships--the conductance (volume) technique.
Topics: Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Catheterization; Cardiac Pacing, Artificial; Cardiac Volume; Computer Graphics; Coronary Angiography; Coronary Disease; Enoximone; Heart Failure; Humans; Imidazoles; Myocardial Contraction; Myocardial Ischemia; Phosphodiesterase Inhibitors; Stroke Volume; Ventricular Function, Left | 1992 |